Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Work In Process (2017 - 2026)

Dexcom has reported Work In Process over the past 13 years, most recently at $136.0 million for Q1 2026.

  • Quarterly Work In Process rose 111.51% to $136.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $136.0 million through Mar 2026, up 111.51% year-over-year, with the annual reading at $105.0 million for FY2025, 273.67% up from the prior year.
  • Work In Process was $136.0 million for Q1 2026 at Dexcom, up from $105.0 million in the prior quarter.
  • Over five years, Work In Process peaked at $136.0 million in Q1 2026 and troughed at $15.8 million in Q1 2022.
  • The 5-year median for Work In Process is $36.4 million (2023), against an average of $51.6 million.
  • Year-over-year, Work In Process fell 12.97% in 2023 and then skyrocketed 273.67% in 2025.
  • A 5-year view of Work In Process shows it stood at $17.2 million in 2022, then surged by 74.42% to $30.0 million in 2023, then dropped by 6.33% to $28.1 million in 2024, then skyrocketed by 273.67% to $105.0 million in 2025, then rose by 29.52% to $136.0 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Work In Process are $136.0 million (Q1 2026), $105.0 million (Q4 2025), and $78.6 million (Q3 2025).